Cargando…
Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103900/ https://www.ncbi.nlm.nih.gov/pubmed/32232552 http://dx.doi.org/10.1007/s00296-020-04570-z |
| _version_ | 1783512139453956096 |
|---|---|
| author | Georgiev, Tsvetoslav |
| author_facet | Georgiev, Tsvetoslav |
| author_sort | Georgiev, Tsvetoslav |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7103900 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71039002020-03-31 Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs Georgiev, Tsvetoslav Rheumatol Int Correspondence Springer Berlin Heidelberg 2020-03-30 2020 /pmc/articles/PMC7103900/ /pubmed/32232552 http://dx.doi.org/10.1007/s00296-020-04570-z Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Correspondence Georgiev, Tsvetoslav Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs |
| title | Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs |
| title_full | Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs |
| title_fullStr | Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs |
| title_full_unstemmed | Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs |
| title_short | Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs |
| title_sort | coronavirus disease 2019 (covid-19) and anti-rheumatic drugs |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7103900/ https://www.ncbi.nlm.nih.gov/pubmed/32232552 http://dx.doi.org/10.1007/s00296-020-04570-z |
| work_keys_str_mv | AT georgievtsvetoslav coronavirusdisease2019covid19andantirheumaticdrugs |